1. Home
  2. News and insight
  3. News
  4. Press releases
1 February 2021

Meet the TauRx Team Video Series Launched

Introducing our new Meet the TauRx Team series!

TauRx have launched a new monthly Meet the Team video series, introducing some of the people who contribute to the important work of TauRx.

First up we have our Chief Operating Officer, Dr Glenn Corr who discusses what is inspirational about working for TauRx and his hope for the future of Alzheimer's disease treatment.

Look out for future Meet the Team videos! Watch Dr Glenn Corr's video here or below.

More news

30 July 2024
MHRA confirms acceptance of UK Marketing Authorisation Application for HMTM
1 July 2024
TauRx submits UK marketing authorisation application for HMTM as a treatment for Alzheimer’s disease
Doctor examining MRI, MRT, CT scan image of human brain. Medical treatment concept. Diagnosis of the disease humans head. Close up.
7 March 2024
Two year sustained cognitive benefits of Hydromethylthionine Mesylate (HMTM) indicated by TauRx’s LUCIDITY trial

Further reading

Our history

For decades, Professor Claude Wischik, co-founder and CEO of TauRx, has led a scientific research team dedicated to finding an effective treatment for neurodegenerative diseases.
Doctor or nurse caregiver with senior couple at home or nursing home
Clinical trials

TauRx recently completed its latest Phase III clinical trials in Alzheimer’s disease and in the rare neurodegenerative disorder, behavioural variant frontotemporal dementia (bvFTD).
Gears. Cog mechanism, engine system, operation progress, gear shift, industry innovation, engineering solution, technology concept.
Environmental, Social and Governance at TauRx

Maintaining integrity, accountability and transparency in our pursuit of life-changing treatments